×
SiBone Total Long-Term Assets 2017-2024 | SIBN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
SiBone total long-term assets from 2017 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
View More
SiBone Total Long-Term Assets 2017-2024 | SIBN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
SiBone total long-term assets from 2017 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$197.4B
Intuitive Surgical (ISRG)
$196.1B
Alcon (ALC)
$42.2B
Edwards Lifesciences (EW)
$41.5B
IQVIA Holdings (IQV)
$35.9B
IDEXX Laboratories (IDXX)
$34.3B
DexCom (DXCM)
$29.1B
Waters (WAT)
$21.9B
STERIS (STE)
$21.3B
SONOVA HOLDING (SONVY)
$20.5B
Hologic (HOLX)
$18.3B
Fresenius Medical Care AG KGaA (FMS)
$12.9B
Sysmex ADR (SSMXY)
$12.8B
Globus Medical (GMED)
$11.6B
Penumbra (PEN)
$9.2B
Masimo (MASI)
$9.1B
Teleflex (TFX)
$8.9B
Glaukos (GKOS)
$7.8B
PROCEPT BioRobotics (PRCT)
$4.9B
Integer Holdings (ITGR)
$4.6B
Veracyte (VCYT)
$3B
Inari Medical (NARI)
$2.9B
LivaNova (LIVN)
$2.8B
TransMedics (TMDX)
$2.7B
Nihon Kohden (NHNKY)
$2.4B
Elekta AB (EKTAY)
$2.1B
Tandem Diabetes Care (TNDM)
$2B
RxSight (RXST)
$1.8B
Integra LifeSciences Holdings (IART)
$1.8B
Alphatec Holdings (ATEC)
$1.4B